
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Human gene transfer is widely regarded as one of the most promising technologies for the treatment of a variety of disorders, but it presents practitioners with a variety of difficult ethical questions. Gene Transfer and the Ethics of First-in-Human Research examines the ethical and policy dimensions of testing interventions in human beings for the first time. The book discusses the difficult ethical challenges that arise from attempting to translate laboratory discoveries into clinical applications. These range from which available techniques to use, when to initiate human testing, questions of consent, expectation in public arenas, how to define acceptable risk, and the inclusion of vulnerable or disadvantaged subjects in early phase trials. This book is relevant to ethicists, legal practitioners, policy makers, geneticists and clinicians involved in clinical trials of new medical interventions
The development of gene transfer technologies presents profound ethical dilemmas when moving from the laboratory to human trials. Jonathan Kimmelman's work investigates the complex ethical and policy considerations inherent in first-in-human research for gene transfer interventions. The book addresses critical questions concerning the selection of techniques, the timing of human testing, the nuances of informed consent, managing public expectations, defining acceptable risk levels, and ensuring the ethical inclusion of vulnerable populations in early-phase trials.
The book is recognized for its thorough examination of the ethical landscape surrounding first-in-human gene transfer research. It is considered a valuable resource for professionals grappling with the translation of cutting-edge biomedical discoveries into patient care. The work is particularly noted for its detailed exploration of consent, risk assessment, and the inclusion of vulnerable populations. Its relevance extends to ethicists, legal practitioners, policymakers, and clinicians engaged in the complex field of clinical trials for new medical interventions.
Page Count:
205
Publication Date:
2010-01-01
ISBN-10:
0521690846
ISBN-13:
9780521690843
No comments yet. Be the first to share your thoughts!